hat
Pou nouvo tretman, syantis yo pran mwèl zo pitit pwòp Et enetikman modifye li ap itilize yon viris san risk/danje pou prezante yon travay vèsyon pipiti de youn nan jèn défectueux a nan cellules immunitaire malad la.
eng
For the new treatment, the scientists took the children’s own bone marrow and genetically modified it using a harmless virus to introduce a working version of the faulty gene into the patient’s immune cells.